What is Esperion Therapeutics's revenue?

Esperion Therapeutics (ESPR) reported revenue of $80.1M in Q1 2026.

How has Esperion Therapeutics's revenue changed year-over-year?

Esperion Therapeutics's revenue increased by 23.2% year-over-year, from $65M to $80.1M.

What is the long-term trend for Esperion Therapeutics's revenue?

Over 4 years (2021 to 2025), Esperion Therapeutics's revenue has grown at a 50.6% compound annual growth rate (CAGR), from $78.45M to $403.14M.

Esperion Therapeutics ESPR Revenue

Revenue at other companies

DJT

Trump Media & Technology GroupDJT

$871.2K+6.1%

ADMA BiologicsADMA

$114.49M-0.3%

Cal-Maine FoodsCALM

$666.95M-53.0%

Ollie's Bargain Outlet Holdings, Inc.OLLI

$658.93M+14.2%

PhotronicsPLAB

$209.94M-0.5%

First BanCorpFBP

$258.64M+4.2%

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's revenue?: Esperion Therapeutics (ESPR) reported revenue of $80.1M in Q1 2026.
How has Esperion Therapeutics's revenue changed year-over-year?: Esperion Therapeutics's revenue increased by 23.2% year-over-year, from $65M to $80.1M.
What is the long-term trend for Esperion Therapeutics's revenue?: Over 4 years (2021 to 2025), Esperion Therapeutics's revenue has grown at a 50.6% compound annual growth rate (CAGR), from $78.45M to $403.14M.